What is Diality?
Diality operates as a specialized medical device manufacturer dedicated to transforming the treatment of kidney disease. The company is currently engineering a versatile, high-performance hemodialysis platform designed for seamless integration across diverse clinical environments, including home settings, nursing facilities, hospitals, and specialized dialysis centers. By prioritizing flexibility and personalized treatment protocols, Diality addresses the critical need for adaptable care solutions that empower both physicians and patients. Their market position is defined by a focus on improving clinical outcomes through technological agility, effectively bridging the gap between traditional institutional care and the growing demand for decentralized, patient-controlled dialysis management.
How much funding has Diality raised?
Diality has raised a total of $74.8M across 4 funding rounds:
Series A
$10M
Debt
$350K
Series B
$36.5M
Other Financing Round
$28M
Series A (2019): $10M, investors not publicly disclosed
Debt (2020): $350K led by PPP
Series B (2022): $36.5M, investors not publicly disclosed
Other Financing Round (2023): $28M, investors not publicly disclosed
Key Investors in Diality
Undisclosed Investor
An undisclosed institutional investor providing strategic capital to support the scaling of medical device innovation.
Undisclosed Investor
A venture capital firm focused on backing high-growth healthcare technology companies with transformative potential.
PPP
Public-Private Partnership
What's next for Diality?
With the recent influx of capital, Diality is well-positioned to accelerate its product development lifecycle and expand its operational footprint. The company's strategic roadmap likely involves scaling manufacturing capabilities and navigating the complex regulatory pathways required for widespread clinical adoption. As the firm transitions from development to broader market penetration, the focus will remain on optimizing the user experience for care providers and patients alike. By leveraging this financial backing, Diality aims to solidify its influence in the nephrology space, potentially disrupting existing care models through its commitment to versatile, high-quality dialysis technology that supports personalized treatment regimens in any care setting.
See full Diality company page
